Clinical trials

  • Dry extract from Psilocybe cubensis (15-25:1), extraction solvent: methanol (psilocybin-containing extract) for Treatment-resistant depression
  • cagrilintide and semaglutide for Obesity
  • MITOMYCIN (MITOMYCIN C) for Non‑muscle‑invasive bladder cancer (high‑risk) with FGFR alterations
  • EVENAMIDE for Treatment-resistant schizophrenia | Schizophrenia
  • ALDESLEUKIN for Autism spectrum disorder
  • SZV-1287 for Neuropathic pain
  • ARIPIPRAZOLE for Behaviors that challenge | Abnormal behaviour
  • AZETUKALNER for Bipolar depression
  • BEVACIZUMAB for HER2-positive metastatic colorectal cancer
  • FINERENONE for Heart failure | Left ventricular systolic dysfunction
  • Iloprost for Sickle cell disease with vaso-occlusive crisis
  • HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST CRLF2 for Severe asthma